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Abstract
RNA-sequencing is rapidly becoming the method of choice for studying the full complexity
of transcriptomes, however with increasing dimensionality, accurate gene ranking is
becoming increasingly challenging. This paper proposes an accurate and sensitive gene
ranking method that implements discriminant non-negative matrix factorization (DNMF) for
RNA-seq data. To the best of our knowledge, this is the first work to explore the utility of
DNMF for gene ranking. When incorporating Fisher’s discriminant criteria and setting the
reduced dimension as two, DNMF learns two factors to approximate the original gene
expression data, abstracting the up-regulated or down-regulated metagene by using the
sample label information. The first factor denotes all the genes’ weights of two metagenes
as the additive combination of all genes, while the second learned factor represents the
expression values of two metagenes. In the gene ranking stage, all the genes are ranked as
a descending sequence according to the differential values of the metagene weights.
Leveraging the nature of NMF and Fisher’s criterion, DNMF can robustly boost the gene
ranking performance. The Area Under the Curve analysis of differential expression analysis
on two benchmarking tests of four RNA-seq data sets with similar phenotypes showed that
our proposed DNMF-based gene ranking method outperforms other widely used methods.
Moreover, the Gene Set Enrichment Analysis also showed DNMF outweighs others. DNMF
is also computationally efficient, substantially outperforming all other benchmarked meth-
ods. Consequently, we suggest DNMF is an effective method for the analysis of differential
gene expression and gene ranking for RNA-seq data.
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Introduction
RNA-sequencing (RNA-seq) is a powerful transcriptome analysis method to identify differen-
tial transcript expression between different biological states. It is commonly considered supe-
rior to fixed transcriptome analysis platforms such as microarrays, however the complexity of
the data generated by the technique presents some inherent challenges to accurate interpreta-
tion. Generally, a list of differentially expressed genes will be obtained using an arbitrary
threshold (such as a P-value< 0.05 after correction for multiple testing). A statistical false dis-
covery threshold can be used to identify those genes most likely related to a given phenotype
[1]. But this strategy inevitably leads to a loss of information, which could otherwise inform on
the full complexity of a biological mechanism or process. An alternative approach to tackle this
problem, is to rank genes in a logical order of differential expression, rather than on the basis
of a somewhat arbitrary statistical threshold [2].
Implementation of an accurate gene ranking is an important prior step to downstream anal-
ysis, such as Gene Set Enrichment Analysis (GSEA), which is more likely to result in biologi-
cally meaningful insights into the underlying biology of the condition or process being studied.
GSEA provides some built-in metrics for ranking genes produced in microarray experiments,
such as Signal2Noise, tTest, and fold change for categorical phenotypes (see GSEA user guide).
For RNA-seq data, GSEA recommends to use other RNA-seq related differential expression
analysis tools to rank genes. After obtaining the rank of genes, the user can use GSEAPreranked
in GSEA to continue the analysis.
A number of tools have been developed to enable differential expression analysis of RNA-
seq data, such as DESeq [3], edgeR [4], PoissonSeq [5] and gfold [6]. However, their analytical
results usually differ according to the underlying differential expression algorithms applied [7].
To the best of our knowledge, gfold is the only tool which offers a specific capability to rank
genes from RNA-seq data, while other differential expression analysis tools tend to focus on
finding differentially expressed genes. The gfold is a generalized fold change based on the pos-
terior distribution of log fold change for ranking differential genes from RNA-seq data. In gen-
eral, biologists prefer to rank genes according to P-values produced by differential expression
analysis tools, but P-values may not be the most effective gene ranking index. In general it is
unclear which GSEA ranking method is most appropriate for RNA-seq data.
Nonnegative matrix factorization (NMF), proposed in 1999 by Lee and Seung, has been
successfully applied in both face recognition and text mining [8]. NMF is an unsupervised,
parts-based representation and dimension reduction paradigm, which decomposes a non-
negative matrix V into two lower-rank non-negative matrices, i.e., V~WH, via a multiplica-
tive update rule (MUR) [8]. NMF has been in the ascendant since it was first described. It
offers several innate advantages, including an intuitive interpretation of factorization and an
implicit sparse representation of complexity that is well suited to the identification of promi-
nent features [9]. In addition, with the incorporated non-negativity constraints over factor
matrices, NMF is distinguished from principal component analysis (PCA) and singular value
decomposition (SVD) [9]. There are plentiful applications of NMF and its extension to data
rich fields, including neural computing, pattern recognition, signal processing, spectral data
analysis, chemometrics, geophysics and more recently computational biology, such as molec-
ular pattern discovery, class comparison and prediction, cross-platform and cross species
analysis, functional characterization of genes and biomedical text mining [9–15]. Among the
biological applications to date, NMF has been successfully used for differential expression
analysis of microarray data [11]. However, the undirected nature of the method has one
drawback, as NMF performs clustering without leveraging the sample label information.
Although this approach may possess advantages in poorly defined phenotypes, prediction
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performance may be poorer than direct sample assignment where phenotypic characterisa-
tion is precise, which limits NMF as a general tool for differential expression analysis or gene
ranking. The application of NMF to differential expression analysis of RNA-seq data has not
been specifically explored, although NMF has been proposed as a method for normalizing
RNA-seq data [16].
By integrating discriminant terms into NMF, discriminant NMF (DNMF) was developed
by regarding Fisher’s discriminant criterion, i.e., the difference between the within-class scatter
and the between-class scatter, as a penalty term of DNMF [17]. To increase the free degree of
the model parameter, Zafeiriou et al proposed a more flexible DNMF, applied to frontal face
verification [18]. Kotsia et al solved DNMF based on projected gradient method, which is more
suitable for classification tasks [19]. Recently, Lee et al, developed a variant of DNMF, improv-
ing discriminant power by using the trace of between-class scatter and then applied to both
emotion and speech recognition [20, 21]. Collectively, DNMF not only improves the separation
between different classes by the discriminant Fisher’s criterion but also learns the sparse repre-
sentation inherited from NMF.
Here we apply DNMF to gene ranking of RNA-seq data. DNMF is distinct from NMF, by
assigning rather than predicting sample labels. Thus, up-regulated and down-regulated meta-
genes may be more predictive than those generated by NMF. When applied to gene ranking of
RNA-seq data, DNMF provides a more efficient and flexible approach to differential expres-
sion analysis as well as gene ranking, and is computationally more efficient compared with
other routinely used methods.
Methods
RNA-seq test datasets
We used four well-characterized reference RNA-seq datasets (AGR, BGI, NWU, PSU) with a
set of synthetic RNAs from the External RNA Control Consortium (ERCC) at known concen-
trations derived from the Sequencing Quality Control (SEQC) project (GSE47792) [22]. Two
sample groups, A and B, were selected. Sample group A is composed of total RNA from ten
human cell lines, derived from Agilent’s Universal Human Reference RNA (UHRR), while
sample group B is from Life Technologies’Human Brain Reference RNA (HBRR) cell lines,
pooled from multiple donors and several brain regions. Sample group A and B were mixed
with Ambion ERCC RNA Spike-In Mix 1 and 2 accordingly. The two ERCC RNAmixtures in
groups A and B contain various concentrations of four subgroups of the synthetic spike-ins
with a predefined log fold change, resulting in 93 ERCC RNA as a benchmark for evaluating
differential expression analysis.
The AGR dataset and BGI dataset were sequenced by the Illumina HiSeq 2000 platform,
while the NWU dataset and PSU dataset were sequenced by the Life Technologies’ SOLiD
5500 platform. All the libraries were mapped to the GRCg37/hg19 human genome by using the
Subread package [23]. Raw read counts of the four datasets were obtained from the Bioconduc-
tor package seqc [22]. Technical replicates sequenced across different lanes and flow cells were
combined for each sample, as the impact of technical variation is likely to be minor compared
to variation introduced by library preparation or biological variation. Transcripts are repre-
sented by raw read counts in all datasets (see Table 1). To evaluate evidence for differential
expression, the TaqMan qPCR dataset, containing 1044 selected genes, was used to validate dif-
ferential transcript expression. Considering the high quality nature of the SEQC dataset and
the availability of qPCR validation data, we prioritised this above other, more heterogeneous
publically available RNA-seq datasets without qPCR validation data.
DNMF for Gene Ranking
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Gene ranking
Five methods for gene ranking are compared with DNMF. As P-value and log fold change
(LogFC) is often used to evaluate significant results from differential expression analysis and
the up-regulated and down-regulated genes are usually at the top and bottom of the ranked
gene list, respectively, we use the signed P-value to rank genes, where the sign is from LogFC.
Genes with same P-value are ranked based on LogFC. We compare the ranking methods of
the signed P-value from DESeq (DESeq, version 1.16.0), the signed P-value from edgeR
(edgeR, version 3.6.8), the gfold value based method (gfold, version 1.13), the LogFC from
gfold based method (gfoldFC), the tt score statistic from PoissonSeq (PoissonSeq, 1.1.2) and
DNMF. For DESeq and edgeR, the built-in methods are used to normalize the data prior to
DE analysis [24], and the size factor normalization method from DESeq is applied for
DNMF, while gfold utilizes the read count and transcript length directly. Additionally, nor-
malized counts are internally log2 transformed after addition of pseudo counts for the
DNMF method.
Discriminant Non-negative Matrix Factorization (DNMF)
Non-negative Matrix Factorization approximates the original data V by the product of both
factors, i.e.W andH, Thus, NMF can be written as follows:
V WH: ð1Þ
To measure the approximate error (or noise) of (1), we can resort to different distance defi-
nitions such as the Euclidian Distance and Kullback-Leiblur (KL) divergence. Different dis-
tance metrics correspond to different objective functions and reflect the statistical structure of
the original data and the disclosed components. For instance, the Euclidian Distance can iden-
tify the Gaussian noise while the KL divergence can model the Poisson distribution of the data
noise. Here, we employ the KL divergence [25] to evaluate the approximate error in DNMF
[18].
When applied to gene ranking, the gene expression profile is represented by matrix V with
gene in row and sample in column. The objective of DNMF is to minimize the KL divergence







 Vil þ ðWHÞil ð2Þ
where Vil is the row (gene) i and column (sample) l in matrix V,W is a matrix with gene in row
and metagene in column andH is a matrix with metagene in row and sample in column.
Table 1. Description of four RNA-seq datasets.
dataset Platform #reads #transcripts #samples #libraries
AGR Illumina 949945481 24550 8 256
BGI Illumina 657087509 24550 10 384
NWU SOLiD 357571839 24550 10 288
PSU SOLiD 284509053 24550 10 288
#reads: total number of sequence reads; #transcripts: total number of transcripts; #samples: total number of samples and #libraries: total number of
libraries sequenced.
doi:10.1371/journal.pone.0137782.t001
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The vector hj (the j-th column (sample) of the matrix H), is the coefficient vector for the
ρ-th sample of the r-th class (e.g. the control group and treatment group) and denoted as
ZðrÞr ¼ ½ZðrÞr;1    ZðrÞr;k    ZðrÞr;K T ; ð3Þ
where k is the k-th row (metagene) in H.
The mean of the vectors ZðrÞr for the class r is denoted as
mðrÞ ¼ ½mðrÞ1    mðrÞk    mðrÞK T ; ð4Þ
while the mean vector of all the classes of samples as
m ¼ ½m1    mk    mK T : ð5Þ
DNMF incorporates Fisher’s criterion into NMF by maximizing the distance among any
samples from different classes meanwhile minimizing the dispersion between any pairs of sam-
ples in the same class. Thus, we define the within-class scatter matrix and between-class scatter







ðZðrÞr  mðrÞÞðZðrÞr  mðrÞÞT ; ð6Þ
where R is the number of sample classes and Nr is the number of samples in the r-th class. and




NrðmðrÞ  mÞðmðrÞ  mÞ
T
: ð7Þ
The matrix Sw represents the scatter of samples within the same classes and its trace should
be as small as possible; Meanwhile, the matrix Sb denotes the scatter of samples between the







 Vil þ ðWHÞil þ gtr½Swdtr½Sb; ð8Þ
Where γ and δ are relative weighting factors and trmeans trace.
To solve DNMF, Zafeiriou et al. proposed a multiplicative update rule (MUR) for bothW









where a ¼ 2gþ 2sL 
2gþ2s
Nr






















wherein htk;l is the k-th metagene and l-th sample element in t-th iteration and L is the column
number ofH (the number of samples).
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where (11) implements a normalization step and wi,k means the i-th gene and kmetagene ele-
ment of w.
The detailed derivation is given in [18]. In the formulation (38) of [18], the variable μk







since it actually includes this entry, i.e., hkj.
According to (9), (10) and (11), we implement DNMF using R, which is available at CRAN
(http://cran.r-project.org/web/packages/DNMF). In this implementation, we initiate W and H
randomly and then add the total sum of each element in H to the k-th metagene within the r-th
(r = k) class. This step makes DNMF more stable and results in clearly defined up-regulated
and down-regulated metagenes inH. In the case of k = 2 and the control is the first sample
group, the first row ofH is the down-regulated metagene, while the second the up-regulated
metagene. Formally, the down-regulated metagene will be the k-th row ofH if mð1Þk > m
ð2Þ
k , while
the up-regulated metagene will be the k-th row ofH if mð1Þk < m
ð2Þ
k .
Because of the correspondence between the columns ofW and the rows of H, the first col-
umn ofW is the linear combination of down-regulated genes, while the second column ofW is
that of up-regulated genes. TheW represents the weight of each genes in the two regulated
metagenes. Consequently, the rank of genes can be defined as
d ¼W2 W1; ð13Þ
WhereW1 andW2 are the first and second column inW, and the sign of d indicates the reg-
ulation direction.
When applied to gene expression data, DNMF is easily interpretable. Given gene expression
data for n genes inm samples, we represent the data as a n×m-dimensional matrix V, wherein
each entry represents the gene expression of each sample. The decomposed matrixW of size
n×k represents the gene weight in metagenes, while k×m-dimensional H denotes the metagene
expression in sample and the metagene is defined as a nonnegative linear combination of the
genes [10]. With an appropriate cost function and Fisher’s criterion, this type of decomposition
can substantially increase the signal to noise ratio of a dataset. Considering the gene ranking,
setting the k to two will extract the most canonical two metagenes with the Fisher’s criterion.
DNMF tries to make the two rows of H largely different to capture two metagenes representing
the up regulated and down regulated genes, as showed in Fig 1. We can determine which meta-
gene represents the up-regulated metagene or the down-regulated metagene in the two rows of
matrix H based on the values. Due to the correspondence between the columns ofW and the
rows of H, we can determine which metagene is the up-regulated or down-regulated metagene
in the two column of matrixW. The up-regulated (or down-regulated) metagene is the linear
combination of all the genes with the value representing the weight of as up-regulated genes
(or down-regulated). In other words, the metagene can be viewed as a combination of highly
DNMF for Gene Ranking
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weighted differentially expressed genes and low or zero weighted non- differentially expressed
genes. Consequently, it is easy to obtain the rank of up-regulated or down-regulated genes
based on the values (weights) in matrixW. Finally, we can get the rank of genes by the subtrac-
tion between the weights of two metagenes in matrixW. We set two parameters, i.e., gamma
and delta in formula (9), to 0.1 and 0.0001, respectively.
A permutation test is used to estimate the significance of differentially expressed genes,
based on a test implemented by Wang et al [26]. The null hypothesis is that matrixW is non-
discriminative of the sample classification. The permutated ds can be obtained by shuffling the
elements ofWB = 1000 times randomly and then subtracting between two columns ofW.







Iðjdj<jdbi jÞ ; ð14Þ
Where I() is an indicator function, being 1 if true and 0 otherwise, n is the number of genes,
and dbi is the permuted d for gene i in the b-th permutation.
Fig 1. Decomposition of RNA-seq data by DNMF. There are two types of samples, A and B, in the matrix V,
each with four replicates. Via DNMF, two matrices,W andH, are produced. The matrixH possesses the
same column number as matrix V, while the matrixW possesses the same row number as matrix V. To
explain it biologically, the row of H could be viewed as the metagenes (the up-regulated or down-regulated
gene sets), while the column ofW represents the weight of each gene in the metagenes. The two metagenes
in matrixH, represent the up-regulated genes and down-regulated genes respectively. Due to the
correspondence between columns ofW and rows of H, it is possible to identify which metagenes are
combined with the up-regulated or down-regulated gene sets in matrixW. Consequently, it is easy to obtain
the rank of genes by subtraction between the weights of the two metagenes in matrixW. The scaled AGR
dataset is used in this figure.
doi:10.1371/journal.pone.0137782.g001
DNMF for Gene Ranking
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Gene set enrichment analysis (GSEA)
Gene set enrichment analysis is a ranking based gene set enrichment method [2]. Since these
ranking results are not from a built-in GSEA function, we use the GSEAPreranked tool of
GSEA (version 2.1.0) directly. The C2 Canonical pathways (C2CP), C2 KEGG (C2KEGG), and
C5 GO biological process (C5) gene datasets from the Molecular Signatures Database [2] are
used as the test gene datasets. There are 1320 gene sets in the C2CP gene dataset, 186 gene sets
in the C2KEGG gene dataset and 825 gene sets in the C5 gene dataset. The classic scoring
scheme, which penalizes sets for lack of coherence and is the only available scoring scheme for
a pre-ranked gene list, the gene set permutation type and other default parameters were used.
Evaluation Criteria
Three aspects are compared to evaluate the performance of different methods. Firstly, The
Area Under the Curve (AUC) benchmarked by 93 pre-defined ERCC spike-ins is compared.
Three thresholds (0.58, 1 and 2) for absolute logFC are set up. Secondly, with increasing abso-
lute logFC from 0.5 to 2 (incremented by 0.1), the AUC benchmarked by 1044 qPCR validated
genes, is compared too. The pROC package [27] is used for calculating the AUC. Finally,
because sample B in the SEQC project is brain-related among all four datasets, the agreement
of enriched gene sets among all four datasets based on the top 10 enriched gene sets of sample
B for each ranking methods are evaluated and the overlapping enriched gene sets are com-
pared. The code of the full analytic process is available at https://github.com/zhilongjia/
geneRanking.
Results
We compared the performance of a range of different ranking methods. Specifically, we studied
six RNA-seq expression ranking methods, DESeq, DNMF, edgeR, PoissionSeq, gfold and
gfoldFC. Results were compared using canonical pathway (C2CP) gene datasets, KEGG
(C2KEGG) and GO process (C5) gene datasets, respectively. All the detailed results are also
supplemented with the analytic code.
Comparison of MA plots
MA plots are a direct and convenient way to show the distribution of differentially expressed
genes among all genes and the inherent bias of gene ranking methods on the basis of expression
level. The distribution of variance and signal strength of the top 1000 differentially expressed
genes identified by all six methods on the AGR dataset are shown in Fig 2. The results on the
remaining three datasets are shown in S1–S3 Figs. As shown in Fig 2, DNMF had less prefer-
ence for genes with larger expression when compared to edgeR and DESeq, though gfold and
gfoldFC performed best among them. However, compared to gfold and gfoldFC, DNMF pre-
ferred with medium expressed genes than very low expressed genes. We believe this bias is
desirable because the logFC of genes with very low expression is more prone to error and can
often lead to confounding outliers in gene expression analysis. The agreement of enriched gene
sets illustrates that this kind of bias is desirable in the analysis of differential gene expression.
In addition, in a similar manner to DESeq and edgeR, DNMF chose up-regulated and down-
regulated genes more equally than gfold, gfoldFC and PoissonSeq (S4 Fig). The top 10 genes on
the other three datasets showed similar behaviour (data not shown).
DNMF for Gene Ranking
PLOS ONE | DOI:10.1371/journal.pone.0137782 September 8, 2015 8 / 15
Comparison of differential expression analysis based on ERCC data and
qPCR validated data
We evaluated the ability of the six methods to detect differentially expressed genes based on
ERCC data, representing genes with a range of LogFCs. Accordingly, it is possible to test how
well all the tested methods correctly detect the extent of differential expression. ERCC with
absolute LogFC more than 0.58, 1 and 2 are considered as differentially expressed, while the
rest are non-differentially expressed. We performed an AUC analysis to compare the perfor-
mance of all six methods in identifying differentially expressed ERCC (Fig 3A). Overall,
DNMF outperformed the other methods in most situations, though gfoldFC worked compara-
bly in some situations. Collectively, DNMF is the optimum method for differential expression
analysis of RNA-seq data in this comparison.
Due to the limited number of ERCC spike-ins available, we further tested the performance
of the six methods based on a more comprehensive benchmarked dataset with qPCR valida-
tion, spanning a wider range of LogFC and sampling a wider transcript population [28]. We
measured AUC at increasing cutoffs of log2 qPCR expression changes, defining differentially
expressed genes as genes above the absolute LogFC. The results are shown in Fig 3B. Generally,
all methods performed comparably on all the four datasets with a slight advantage of gfoldFC
and DNMF. However, DNMF outperformed other methods at lower logFC thresholds.
Comparison of enriched gene set agreement among all datasets
It is one of the fundamental goals of GSEA to obtain a consistent signal from independent data-
sets concerning the same study objective or phenotype. Accurate identification of a true signal,
Fig 2. MA plot of top 1000 differentially expressed genes in the AGR dataset identified by 6methods.
The means of two different kinds of samples in the data are used. Red dots indicate differentially expressed
genes. Black dots indicate non-differentially expressed genes.
doi:10.1371/journal.pone.0137782.g002
DNMF for Gene Ranking
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overcoming the confounding influence of biological and experimental noise is the acid test of
gene set enrichment analysis. Because sample B is derived from multiple brain regions, we per-
formed GSEA based on three gene datasets (C2CP, C2KEGG and C5) on all four expression
datasets and then investigated the agreement of enriched gene sets related to sample B between
all four expression datasets using the top 10 enriched gene sets (more details shown in
Table 2). From Table 2, the largest number of overlapping C2CP gene sets are 9/10, obtained
by DNMF and gfoldFC methods. The edgeR and DNMF methods showed 9/10 gene overlap
among all four datasets on the C2KEGG gene dataset. In the case of C5 gene datasets, all the
methods tied, each obtaining the largest (9/10 gene sets) among all the ranking methods. As
the four datasets are obtained from two RNA-seq platforms, Illumina and SOLiD, DNMF
achieved higher consistence of gene sets than that of the compared methods in balance,
although all methods performed well.
We also evaluated the biological content of enriched gene sets. S1 Table details the consis-
tent gene sets obtained by DNMF on the C2CP, C2KEGG and C5 gene sets. Pooled from
Fig 3. AUC curve of differential expression analysis using ERCC and qPCR validated data. (A) The cutoffs of absolute log fold change (LogFC) (0.58, 1
and 2) are used. DNMF works best in most cases. (B) At increasing LogFC, the performance of DNMF and gfold shows a slight advantage over other
methods, while at lower logFC thresholds, DNMF generally outperformed other methods. AUC, area under the curve.
doi:10.1371/journal.pone.0137782.g003
Table 2. Overlap of the top10 gene sets enriched by 6 different gene-rankingmethods on four datasets for the C2CP, C2KEGG and C5 gene
datasets.
DESeq DNMF edgeR gfold gfoldFC PossionSeq
C2CP 8 9 8 7 9 8
C2KEGG 7 8 8 6 7 7
C5 9 9 9 9 9 9
doi:10.1371/journal.pone.0137782.t002
DNMF for Gene Ranking
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several brain regions, the enriched gene sets for sample group B should be relevant to brain-
function. As we can see from the canonical pathway dataset (C2CP) in S1 Table, reactome of
neuronal system, chemical synapses transmission, olfactory, neural related function in postsyn-
aptic cell, and neurotransmitter release cycle are enriched. Furthermore, potassium channel
[29] and calcium signalling are also enriched. Similar results are found in the KEGG gene set.
For biological process within Gene Ontology (C5), neural related processes, such as nervous
system development, neurological system process, nerve impulse and potassium ion transport,
are enriched. From S1 Table, we can conclude that the overlapped gene sets are highly related
with the phenotype of the sample.
Next, we analysed by GSEA the leading edge subset of the top 10 C2CP gene set for sample
B in the AGR dataset. Genes in many of the leading edge subsets are more likely to be interest-
ing than genes that are only seen in a few of the leading-edge subsets [2]. As a result, genes seen
most frequently in the top 10 gene sets were obtained (see Fig 4). No gene was present in all the
10 gene sets. The leading edge genes identified by all the methods except DESeq are similar.
More specifically, three leading edge genes (GNAL, GABBR1 and GABBR2) obtained by
DNMF and gfold are involved in neuroactive ligand receptor interaction pathway from KEGG
[30]. At the same time, leading edge genes identified by DESeq are relevant with Long-term
Fig 4. Venn diagram of leading edge genes among the leading edge subsets for all methods. The leading edge genes are highly overlapped from
methods except DESeq. All the leading edge genes are relevant to brain-function.
doi:10.1371/journal.pone.0137782.g004
DNMF for Gene Ranking
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potentiation (LTP) pathway from KEGG. LTP is one of the major cellular mechanisms that
underlies learning and memory [31].
Comparison of computation time
We tested the runtime of all compared methods for ranking genes on the NWU dataset on an
8-core 3.4GHz, 16GB RAM, Debian desktop PC. DNMF only spent 0.78 seconds, while edgeR
took 3.94 seconds, DESeq 2.22 minutes, PoissonSeq 3.68 seconds, gfold 482.94 seconds and
DESeq 133.2 seconds. Moreover, in order to check the scalability of DNMF on larger datasets,
we used the original NWU dataset with 120 samples from different lanes and flowcells. Only
3.37 seconds were spent on this large dataset. The efficiency of DNMF largely results from
NMF itself and specific initiation of H in DNMF we used. Consequently, DNMF runtime sub-
stantially outperformed other methods and scaled well on large datasets.
Discussion
We leverage Discriminant Non-negative Matrix Factorization (DNMF), a machine learning
method, to rank genes identified by RNA-seq analysis. This paper evaluates the performance of
our proposed DNMF-based gene ranking method by comparing with the state-of-the-art
methods including DESeq, edgeR, PoissonSeq, gfoldFC and gfold, across a range of analytical
perspectives. We conclude that DNMF performs well in a number of aspects. Firstly, gene
ranking by DNMF is less affected by gene expression levels. Although Fisher criterion is used
in DNMF and subtraction is used in the difference between-class, we logged gene expression
data so that division is used in the difference between-class in unlogged data. The log operation
for DNMF also results in almost no bias towards genes with larger read counts. Secondly, theo-
retically, gene ranking can be considered as an extension of differential expression analysis. We
tested the performance of DNMF on the benchmarked differentially expressed genes defined
by both ERCC spike-ins and qPCR validated data. Accordingly, we employ AUC curves to
evaluate different ranking methods. DNMF consistently outperforms the representative meth-
ods in most cases, indicating a high sensitivity and specificity. Thirdly, the performance of gene
set enrichment analysis is largely dependent on the relative rank of genes. As the four datasets
involve samples from directly comparable tissues, we selected the top 10 enriched gene sets
from the results of all four datasets sourcing from each ranking method to test the consistency
between the enriched gene sets. Compared with others, the proposed DNMF-based ranking
method shows a high degree of consistency between the enriched gene sets based on three gene
datasets. Moreover, the enriched gene sets are biologically related with the sample. Collectively,
we believe the comparisons demonstrate that DNMF may provide a more biologically mean-
ingful gene rank resulting in more robust gene sets and pathways for further investigation.
The reason why DNMF outperforms other methods probably resides in three aspects.
Firstly, depending on the objective function used, DNMF appears to be quite robust to noise
within data, even after incorporating Fisher’s criterion with an accompanying disruption to the
originally modelled noise distribution of the data set. Secondly, DNMF can efficiently and
effectively identify the up-regulated and down-regulated metagenes, benefitting from the non-
negative constraints, Fisher’s criterion, subtle initiation of H and the simplified selection of two
dimensions. With different weight assigned to different genes, the two metagenes play a critical
role in gene ranking. In addition, in a similar manner to NMF, DNMF has potential to learn
sparse and parts-based representation (such as a nose on a facial image), and therefore DNMF
can differently weight genes that potentially play different roles in different kinds of samples,
as evidenced by sample specific expression behaviours. As the weight of genes will have a high
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impact on the gene ranking and on the power of the subsequent tests, DNMF can identify a
biologically and statistically meaningful rank of genes.
DNMF still has a theoretical shortcoming that it cannot always identify the up-regulated
and down-regulated metagenes when there is a convergence to a stationary limit point. Thus, if
the coefficient H does not represent the up-regulated and down-regulated metagenes, a rerun
of DNMF is required until the condition satisfies. Note that our DNMF source code will guide
the user to perform this operation if required. At the same time, as a differential expression
analysis tool, DNMF cannot deal with multi-factored experiments like edgeR or DESeq or
experiments without replicates like gfold.
We have developed a simple DNMF package to enable convenient gene ranking in gene
expression experiments. The tolerable computational cost of the algorithm makes it competi-
tive with other more intensively computational methods. DNMF provides an effective gene-
ranking method, and is also extensible to other genes ranking functions, such as rank-based
similarity measures for gene expression data [32], besides GSEA. Furthermore, DNMF can be
used as a differential expression analysis tool by selecting the top genes in the up-regulated and
down-regulated metagenes in a similar manner to that used by Kong et al [11]. DNMF may
also be applicable for the large scale meta-analyses of gene expression data measured on differ-
ent platforms towards a consensus on gene sets in key diseases and biological traits. The
DNMF approach could be generically applied to other fields allied to and beyond biology, such
as the challenging and high dimensional interface between chemistry and biology which is
often a barrier during the process of drug discovery. In conclusion, we have shown a novel
application of DNMF for gene ranking of RNA-seq gene expression data, which greatly outper-
forms other representative methods in benchmark testing.
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